IQVIA Holdings, Inc. (IQV) Stock Analysis
Healthcare · Diagnostics & Research
Sell if holding. At $179.17, A.R:R 1.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.6): -1.5; Negative momentum.
IQVIA is a global provider of clinical research services, commercial intelligence, and healthcare analytics to life sciences and healthcare clients, with ~93,000 employees in 100+ countries. It operates through Technology & Analytics Solutions, Research & Development Solutions,... Read more
Sell if holding. At $179.17, A.R:R 1.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.6): -1.5; Negative momentum. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.3/10, high confidence.
Passes 5/9 gates (clean insider activity, news events none recent, earnings proximity 35d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: moderate.
Recent developments
updated 2026-06-17Recent Developments — IQVIA Holdings, Inc.
Latest news
- NEWS A Look At IQVIA Holdings (IQV) Valuation After ESOP Linked Shelf Registration For Potential Share Issuance - Yahoo Finan — Yahoo Finance neutral
- NEWS IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? - Yahoo Finance — Yahoo Finance positive
- NEWS Vanguard Group Inc. Acquires 159,899 Shares of IQVIA Holdings Inc. $IQV - MarketBeat — MarketBeat positive
- NEWS IQVIA Holdings Inc. 2026 Q1 - Results - Earnings Call Presentation (NYSE:IQV) 2026-05-05 - Seeking Alpha — Seeking Alpha neutral
- NEWS IQVIA Holdings Inc Stock (IQV) Closed Up by 9.60% on May 5: Key Drivers Unveiled - TradingKey — TradingKey positive
Generated 2026-06-17T09:07:23Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-04-23Item 5.02LOWStockholders approved the 2026 Incentive and Stock Award Plan at the April 23, 2026 Annual Meeting, increasing reserved shares by 5M (to 125.35M total), extending plan term to January 29, 2036, and specifying change-of-control award treatment.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $179.17, A.R:R 1.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.6): -1.5; Negative momentum. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $166.63. Score 5.3/10, high confidence.
Take-profit target: $204.25 (+14.0% upside). Prior stop was $166.63. Stop-loss: $166.63.
Leverage penalty (D/E 2.6): -1.5; Negative momentum; Below 200-day MA.
IQVIA Holdings, Inc. trades at a P/E of 22.2 (forward 12.6). TrendMatrix value score: 7.1/10. Verdict: Sell.
30 analysts cover IQV with a consensus score of 4.1/5. Average price target: $227.
What does IQVIA Holdings, Inc. do?IQVIA is a global provider of clinical research services, commercial intelligence, and healthcare analytics to life...
IQVIA is a global provider of clinical research services, commercial intelligence, and healthcare analytics to life sciences and healthcare clients, with ~93,000 employees in 100+ countries. It operates through Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions segments; no single client exceeded 10% of revenue in 2025.